AE Wealth Management’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-97,751
Closed -$87.9K 1345
2024
Q2
$87.9K Buy
+97,751
New +$113K ﹤0.01% 1200
2024
Q1
Sell
-41,684
Closed -$36.6K 2064
2023
Q4
$36.6K Hold
41,684
﹤0.01% 1992
2023
Q3
$89.2K Buy
41,684
+1
+0% +$2 ﹤0.01% 1846
2023
Q2
$159K Buy
41,683
+16,666
+67% +$62.2K ﹤0.01% 1768
2023
Q1
$69.8K Buy
25,017
+16,667
+200% +$68.5K ﹤0.01% 1806
2022
Q4
$22.4K Buy
+8,350
New +$46.1K ﹤0.01% 1784

Other funds holding BTCY

AE Wealth Management's BTCY Position: Q3 2024 in Review

AE Wealth Management sold out of Biotricity, Inc. Common Stock (BTCY) in Q3 2024, closing a stake of 97,751 shares — an estimated $87.9K sold.

AE Wealth Management first reported a position in BTCY in Q4 2022 and held it in 6 quarters. The position peaked at $159K in Q2 2023. 5 funds tracked by Wall St. Rank hold BTCY as of Q3 2024.

  • AE Wealth Management reported no remaining Biotricity, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • AE Wealth Management sold 97,751 Biotricity, Inc. Common Stock shares in Q3 2024, an estimated $87.9K.
  • AE Wealth Management first reported a position in Biotricity, Inc. Common Stock in Q4 2022 and held it in 6 quarters.
  • AE Wealth Management's Biotricity, Inc. Common Stock position peaked at $159K in Q2 2023.
  • 5 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q3 2024.

Based on AE Wealth Management's 13F filing for Q3 2024, filed 14 Nov 2024.